Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photobiomodulated PRP for Androgenetic Alopecia
NCT07739147Phase 1Not yet recruiting
- Start
- Dec 2026
- Primary completion
- Dec 2027
01
Overview
Phase 1, randomised, single-blind trial of platelet-rich plasma injection in androgenetic alopecia (AGA) (3 arms). Primary endpoints: Hair rate Terminal/Vellus at 12 months and Hair Density at 12 months. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
platelet-rich plasma injection
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT07739147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07739147.